Last reviewed · How we verify

IL-YANG Flu Vaccine Prefilled Syringe — Competitive Intelligence Brief

IL-YANG Flu Vaccine Prefilled Syringe (IL-YANG Flu Vaccine Prefilled Syringe) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated influenza vaccine. Area: Immunology.

phase 3 Inactivated influenza vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

IL-YANG Flu Vaccine Prefilled Syringe (IL-YANG Flu Vaccine Prefilled Syringe) — Il-Yang Pharm. Co., Ltd.. IL-YANG Flu Vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains included in the vaccine formulation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
IL-YANG Flu Vaccine Prefilled Syringe TARGET IL-YANG Flu Vaccine Prefilled Syringe Il-Yang Pharm. Co., Ltd. phase 3 Inactivated influenza vaccine
SP Shz TIV SP Shz TIV Sanofi marketed Inactivated influenza vaccine
Vaxigrip Tetra Sanofi Pasteur Europe Vaxigrip Tetra Sanofi Pasteur Europe Aarhus University Hospital marketed Inactivated influenza vaccine (quadrivalent)
Flublok™ Quadrivalent by Sanofi, Inc. Flublok™ Quadrivalent by Sanofi, Inc. Centers for Disease Control and Prevention marketed Recombinant inactivated influenza vaccine Influenza hemagglutinin (HA) protein
Hualan TIV Hualan TIV Sanofi marketed Inactivated influenza vaccine
ccIIV4 ccIIV4 Vanderbilt University Medical Center marketed Inactivated influenza vaccine
Fluad alone Fluad alone Korea University Guro Hospital marketed Inactivated influenza vaccine with adjuvant Influenza virus hemagglutinin and neuraminidase antigens; MF59 acts as immunological adjuvant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated influenza vaccine class)

  1. GlaxoSmithKline · 16 drugs in this class
  2. Seqirus · 5 drugs in this class
  3. Sanofi Pasteur, a Sanofi Company · 5 drugs in this class
  4. Green Cross Corporation · 4 drugs in this class
  5. Novartis · 2 drugs in this class
  6. SK Chemicals Co., Ltd. · 2 drugs in this class
  7. Sanofi · 2 drugs in this class
  8. Hospital Israelita Albert Einstein · 2 drugs in this class
  9. McGill University Health Centre/Research Institute of the McGill University Health Centre · 2 drugs in this class
  10. Il-Yang Pharm. Co., Ltd. · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). IL-YANG Flu Vaccine Prefilled Syringe — Competitive Intelligence Brief. https://druglandscape.com/ci/il-yang-flu-vaccine-prefilled-syringe. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: